CDC Emerging Infections · Jun 23, 2026
Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022–2024
P. Roychoudhury et al.
Latest medical news · page 160
The latest headlines across every section, pulled from official and open-access sources.
CDC Emerging Infections · Jun 23, 2026
Ancylostoma ceylanicum Hookworm, Rural Papua New Guinea, 2020
J. L. Scott et al.
CDC Emerging Infections · Jun 23, 2026
New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States
B. J. Glasgow et al.
CDC Emerging Infections · Jun 23, 2026
Molecular Confirmation of Autochthonous Taenia saginata Infection, Timor-Leste, 2019
H. Jin et al.
CDC Emerging Infections · Jun 23, 2026
Discovery of Cinchona as Antimalarial, Viceroyalty of Peru, Circa 1630
J. Rojas-Jaimes et al.
CDC Emerging Infections · Jun 23, 2026
Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016–2024
V. Hernando et al.
CDC Emerging Infections · Jun 23, 2026
Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022–2023
S. F. Randrianarisoa et al.
CDC Emerging Infections · Jun 23, 2026
Neurologic Alveolar Echinococcosis in Postpartum Zoo-Housed Gorilla, the Netherlands, 2024
L. Derks et al.
CDC Emerging Infections · Jun 23, 2026
Emergence of West African Human T-Lymphotropic Virus 1aC Subgroup, Brazilian Amazon
J. de Melo Silva et al.
CDC Emerging Infections · Jun 23, 2026
Dracunculus sp. PantanalBr Infection in Florida Panthers and Bobcat, Florida, USA
M. J. Yabsley et al.
MedCity News · Jun 23, 2026
Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts
Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program. The post Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts appeared first on MedCity News .
JAMA Network Open · Jun 23, 2026
Why the Test-Negative Design is Used for Routine Vaccine Monitoring
Infectious Diseases
JAMA Network Open · Jun 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults
This case-control study estimates vaccine effectiveness of 2025-2026 COVID-19 vaccines among adults with COVID-19–associated emergency department or urgent care encounters and COVID-19–associated hospitalizations.
JAMA Network Open · Jun 23, 2026
Maternal Cardiovascular Health During Pregnancy and Offspring Developmental Delay
This cohort study assesses whether maternal cardiovascular health during pregnancy is associated with a delay in communication, gross motor, fine motor, problem solving, and personal-social skills among offspring in participants of the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study in Japan.
JAMA Network Open · Jun 23, 2026
Environmental Menu Labels and Food Selection Among US Adults
This randomized clinical trial examines the potential for climate labels on fast food menus to encourage more sustainable and healthier food choices.
JAMA Network Open · Jun 23, 2026
Palliative Care Coaching for Family Caregivers of Patients With Advanced Cancer
This randomized clinical trial examines the effect of a lay coach–led, early palliative care telehealth intervention for family caregivers of patients with advanced cancer on caregiver distress and patient quality of life outcomes.
JAMA Network Open · Jun 23, 2026
Development of an AI System for Generating Clinical Urine Drug Test Sign-Outs
This prognostic study describes the development, deployment, and evaluation of an artificial intelligence (AI) language tool for generating preliminary sign-outs to support a urine drug testing service.
JAMA Network Open · Jun 23, 2026
Psychosocial Interventions Plus Buprenorphine for Opioid Abstinence
This randomized clinical trial of US adults examines the efficacy of cognitive-behavioral therapy and peer recovery support for opioid abstinence when combined with buprenorphine treatment.
JAMA Network Open · Jun 23, 2026
Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials
This systematic review of US-based randomized clinical trials in oncology examines the prevalence of reporting age, sex, race and ethnicity, rurality, income, education, insurance, and area-level deprivation of patient cohorts between 2020 and 2025.
JAMA Network Open · Jun 23, 2026
Neighborhood Disinvestment, Race, and Age of Hypertension Onset in Women
This cohort study evaluates racial disparities in early hypertension onset among women and examines the degree to which these disparities vary across levels of neighborhood socioeconomic disinvestment.
FDA Drugs · Jun 22, 2026
Ongoing | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.
FDA Drugs · Jun 22, 2026
Withdrawn | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been subsequently withdrawn, and are therefore, no longer FDA-approved.
MedCity News · Jun 22, 2026
Abarca Health and LucyRx to Combine to Scale Independent PBM Model
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members. The post Abarca Health and LucyRx to Combine to Scale Independent PBM Model appeared first on MedCity News .
FDA Drugs · Jun 22, 2026
Generic Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.